Korak Chakraborti

Korak Chakraborti

Auto-generated profile, based on publicly available information

Korak Chakraborti

Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Science
Verified
Journal Article
Closed access
SPSaba Parvez
Saba Parvez
CHChelsea Herdman
Chelsea Herdman
MBManu Beerens
Manu Beerens
KCKorak Chakraborti
Korak Chakraborti
ZHZachary P. Harmer
Zachary P. Harmer
RPRandall T. Peterson
Randall T. Peterson
Screen time for CRISPR: CRISPR-Cas9 has been used to edit the genomes of organisms ranging from fruit flies to primates, but it has not been used in large-scale genetic screens in animals because generating, validating, and keeping track of large numbers of mutant animals is prohibitively laborious. Parvez et al . have developed Multiplexed Intermixed CRISPR Droplets, or MIC-Drop, a platform combining droplet microfluidics, en masse CRISPR injections, and barcoding, to enable large-scale genetic screens. In pilot phenotypic screens in zebrafish, MIC-Drop enabled rapid identification of the target of a small molecule and discovery of several new genes governing cardiovascular development. MIC-Drop is potentially scalable to thousands of targets and adaptable to diverse organisms and experiments. —DJ

29 October 2025 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
SBSujana Balla
Sujana Balla
KCKorak Chakraborti
Korak Chakraborti
NJNaman Jain
Naman Jain
JRJack Ruske
Jack Ruske
KSKevin S. Shah
Kevin S. Shah